EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study

Lori McLeod, Claire Ervin, Sheri E Fehnel, Sonya Eremenco, Robyn T Carson, Jennifer Hanlon, Stephen Joel Coons, Patient-Reported Outcome Consortium’s Irritable Bowel Syndrome Working Group

Value in Health · 2024

DOI: 10.1016/j.jval.2024.01.013 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Value in Health, 2024. Verfasst von Lori McLeod und 7 weiteren Autor:innen. Beteiligte Einrichtung: RTI Health Solutions, Research Triangle Park, NC, USA. Electronic address: lmcleod@rti.org. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Psychometrics, Constipation, Severity of Illness Index. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: U.S. Department of Health and Human Services, U.S. Food and Drug Administration, Takeda Pharmaceutical Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To evaluate the psychometric properties of the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C), which was developed to support primary and secondary endpoints in irritable bowel syndrome (IBS) with predominant constipation (IBS-C) clinical trials. METHODS: Observational data were collected from 108 adults with IBS-C using a smartphone-type device for 17 days. DIBSS-C data regarding bowel movements (BMs) were collected for each event (along with the Bristol Stool Form Scale); abdominal symptoms were rated each evening. Global status items and the Gastrointestinal Symptom Rating Scale-IBS were completed on day 10 and day 17 and the IBS-Symptom Severity Scale on day 17. Item-level performance, internal consistency reliability, test-retest reliability, and construct validity were evaluated. RESULTS: The Abdominal Symptoms Domain score demonstrated high internal consistency reliability (Cronbach's alpha week 1 = 0.98; week 2 = 0.96) and test-retest reliability (intraclass correlation coefficient [ICC] = 0.93). Test-retest reliability was stronger for abdominal symptoms (ICC = 0.91-0.94) than for the frequency-based BM-related outcomes (ICC = 0.54-0.66). Key construct validity hypotheses were supported by moderate to strong correlations with the corresponding Gastrointestinal Symptom Rating Scale-IBS, IBS-Symptom Severity Scale, and Bristol Stool Form Scale items. All known-groups comparisons were statistically significant for the abdominal symptom items and domain score; evidence for known-groups validity of BM-related outcomes was supportive when based on constipation severity. CONCLUSIONS: The results of this study provided key psychometric evidence for the DIBSS-C, ultimately contributing to its qualification by the US Food and Drug Administration for use in IBS-C clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromePsychometricsConstipationSeverity of Illness IndexHumansFemaleMaleProspective StudiesReproducibility of ResultsAdultMiddle AgedAgedYoung AdultDiaries as Topic

Stichwörter der Autor:innen

IBS with predominant constipationclinical outcome assessmentpatient-reported outcome measurepsychometric evaluation

Autor:innen und Institutionen

  • RTI Health Solutions, Research Triangle Park, NC, USA. Electronic address: lmcleod@rti.org.
  • RTI Health Solutions, Research Triangle Park, NC, USA.
  • Patient-Reported Outcome Consortium, Critical Path Institute, Tucson, AZ, USA.
  • Patient-Centered Outcomes Research, AbbVie, Madison, NJ, USA.
  • IQVIA, Cambridge, MA, USA.
  • Clinical Outcome Assessment Program, Critical Path Institute, Tucson, AZ, USA.

Förderung

  • U.S. Department of Health and Human Services
  • U.S. Food and Drug Administration
  • Takeda Pharmaceutical Company

Zitieren

APA

McLeod, L., Ervin, C., Fehnel, S. E., Eremenco, S., Carson, R. T., Hanlon, J., Coons, S. J., & Patient-Reported Outcome Consortium’s Irritable Bowel Syndrome Working Group (2024). Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study. Value in Health. https://doi.org/10.1016/j.jval.2024.01.013

Vancouver

McLeod L, Ervin C, Fehnel SE, Eremenco S, Carson RT, Hanlon J, et al. Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study. Value in Health. 2024. doi:10.1016/j.jval.2024.01.013

BibTeX
@article{McLeod2024,
  author = {McLeod, Lori and Ervin, Claire and Fehnel, Sheri E and Eremenco, Sonya and Carson, Robyn T and Hanlon, Jennifer and Coons, Stephen Joel and Patient-Reported Outcome Consortium’s Irritable Bowel Syndrome Working Group, Patient-Reported Outcome Consortium’s Irritable Bowel Syndrome Working Group},
  title = {Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study},
  journal = {Value in Health},
  year = {2024},
  doi = {10.1016/j.jval.2024.01.013}
}
Kostenlos starten →